Related Experiment Video
Updated: Mar 21, 2026
08:35
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
4.4K
[Renovascular hypertension]
Joanna Matuszkiewicz-Rowińska1, Monika Wieliczko1
1Katedra i Klinika Nefrologii, Dializoterapii i Chorób Wewnętrznych, Warszawski Uniwersytet Medyczny, Warszawa.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|May 11, 2016
Summary
Renovascular hypertension (RVH), often caused by renal artery stenosis, requires prompt diagnosis and management. Effective treatments include medical therapy and, in select cases, renal revascularization.
Area of Science:
- Cardiology
- Nephrology
- Vascular Medicine
Context:
- Renovascular hypertension (RVH) is a common cause of secondary hypertension.
- Atherosclerotic renal artery stenosis accounts for 90% of RVH cases, often associated with poor prognosis due to widespread occlusive disease.
- Fibromuscular dysplasia underlies RVH in the remaining 10% of patients, typically younger women.
Purpose:
- To outline the clinical suspicion, diagnostic methods, and management strategies for renovascular hypertension.
- To differentiate between atherosclerotic and fibromuscular dysplasia causes of RVH.
- To guide clinicians in identifying patients who may benefit from specific diagnostic and therapeutic interventions.
Summary:
- RVH should be suspected in patients with severe/resistant hypertension, sudden renal function decline, or worsening hypertension post-RAAS antagonist treatment.
- Screening involves Doppler ultrasound, followed by CT or MR angiography.
- Management includes RAAS blockers, aldosterone/calcium antagonists, statins, and antiplatelet agents; renal revascularization is reserved for select cases.
Impact:
- Improved diagnostic accuracy for RVH.
- Optimized medical and interventional treatment strategies for RVH patients.
- Better patient outcomes by addressing the underlying cause of secondary hypertension.
More Related Videos
Related Concept Videos
01:29Hypertension II: Pathophysiology
1.4K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
01:18Hypertension and Regulation of Blood Pressure
4.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.8K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.8K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.8K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.8K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
3.0K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K